Literature DB >> 12494359

Treatment of Chiari malformation, syringomyelia and hydrocephalus by neuroendoscopic third ventriculostomy.

N Buxton1, T Jaspan, J Punt.   

Abstract

This short paper illustrates a case with cervical myelomeningocoele, a Chiari malformation (CM), hydrocephalus (HC) and cervical syringomyelia treated by neuroendoscopic third ventriculostomy (NTV) with resolution of both the hydrocephalus and the syrinx. Two similar cases are discussed. The technique is advocated for the treatment of such complex dysraphic conditions.

Entities:  

Mesh：

Year:  2002        PMID： 12494359     DOI： 10.1055/s-2002-36195

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN： 0946-7211


  5 in total

1.  Pathophysiology of persistent syringomyelia after decompressive craniocervical surgery. Clinical article.

Authors:  John D Heiss; Giancarlo Suffredini; René Smith; Hetty L DeVroom; Nicholas J Patronas; John A Butman; Francine Thomas; Edward H Oldfield
Journal:  J Neurosurg Spine       Date:  2010-12

2.  Simultaneous endoscopic third ventriculostomy and ventriculoperitoneal shunt for infantile hydrocephalus.

Authors:  Kyu-Won Shim; Dong-Seok Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2007-11-10       Impact factor: 1.475

Review 3.  Endoscopic third ventriculostomy for obstructive hydrocephalus.

Authors:  Dieter Hellwig; Joachim Andreas Grotenhuis; Wuttipong Tirakotai; Thomas Riegel; Dirk Michael Schulte; Bernhard Ludwig Bauer; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2004-11-27       Impact factor: 3.042

4.  Decompensated hydrocephalus causing syringomyelia and tetraparesis: a case report.

Authors:  A Peraud; S Grau
Journal:  Childs Nerv Syst       Date:  2008-11-01       Impact factor: 1.475

5.  Application of endoscopic third ventriculostomy for treating hydrocephalus-correlated Chiari type I malformation in a single Chinese neurosurgery centre.

Authors:  Yiping Wu; Chuzhong Li; Xuyi Zong; Xinsheng Wang; Songbai Gui; Caiping Gu; Yazhuo Zhang
Journal:  Neurosurg Rev       Date:  2017-03-22       Impact factor: 3.042
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.